Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Capital Expenditures (2019 - 2025)

AVITA Medical filings provide 7 years of Capital Expenditures readings, the most recent being -$1.0 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 257.53% to -$1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $635000.0, a 452.17% increase, with the full-year FY2025 number at $635000.0, up 452.17% from a year prior.
  • Capital Expenditures hit -$1.0 million in Q4 2025 for AVITA Medical, down from $1.5 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.5 million in Q3 2025 to a low of -$1.0 million in Q4 2025.
  • Median Capital Expenditures over the past 5 years was $65000.0 (2024), compared with a mean of $75647.1.
  • Biggest five-year swings in Capital Expenditures: plummeted 369.23% in 2024 and later skyrocketed 2223.08% in 2025.
  • AVITA Medical's Capital Expenditures stood at $67000.0 in 2021, then tumbled by 620.9% to -$349000.0 in 2022, then soared by 69.05% to -$108000.0 in 2023, then tumbled by 170.37% to -$292000.0 in 2024, then crashed by 257.53% to -$1.0 million in 2025.
  • The last three reported values for Capital Expenditures were -$1.0 million (Q4 2025), $1.5 million (Q3 2025), and -$52000.0 (Q2 2025) per Business Quant data.